REGCP Q1 2026 Earnings Preferred Dividends Beat Estimates with 74 Surprise CRVS Q1 2026 Earnings EPS Misses Estimates as PreCommercial Biotech Continues Pipeline Progress LAMR Q1 2026 Earnings Strong EPS Beat Drives Positive Market Response MCRB Q1 2026 Earnings EPS Misses Estimates Revenue Not Reported Stock Declines OCCI Q1 2026 Earnings Deep EPS Miss Overshadowed by Positive Market Reaction